| Literature DB >> 33357707 |
Qiang Wu1, Fan Yang2, Huaqiao Tang3.
Abstract
The aim of the study is to determine the target of Paeteria scandens in nonalcoholic fatty liver disease (NAFLD). The Chinese herbal medicine pharmacology data and analysis platform were used to search and screen for the effective components of the Paeteria scandens compounds and to analyze the possible therapeutic targets based on network topology. In addition, various known disease target databases were enrolled, the therapeutic target proteins in NAFLD were screened, and a protein-protein interaction network was constructed. Enrichment analysis was performed on key nodes. Finally, the inhibitory effect of Paeteria scandens on NAFLD was verified by experiments. We identified 33 major candidate targets of Paeteria scandens and successfully constructed a "drug-compound-target-disease" network. Abovementioned targets revealed by gene enrichment analysis have played a significant role in the cell cycle, apoptosis, and related signal pathways. We demonstrated that Paeteria scandens downregulated serum triglyceride and lipopolysaccharides levels in NAFLD chickens by feeding with a high-capacity diet and endotoxin of Salmonella enteritidis was given by gavage. Paeteria scandens may regulate the hepatic cell cycle and apoptosis through the Salmonella infection pathway, Toll-like receptor signaling pathway, and apoptosis pathway. For NAFLD, Paeteria scandens may be a promising, long-lasting treatment strategy.Entities:
Keywords: Paeteria scandens; apoptosis; cell cycle; network pharmacology; nonalcoholic fatty liver disease
Mesh:
Substances:
Year: 2020 PMID: 33357707 PMCID: PMC7772706 DOI: 10.1016/j.psj.2020.09.087
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Composition and nutrient levels of the diets.
| Ingredients | Proportion (%) | Nutritional level | |
|---|---|---|---|
| Corn | 53.00 | ME | 16.07 (MJ/kg) |
| Fish meal | 1.00 | CP | 160.0 (g/kg) |
| Fried meal | 29.30 | Ca | 9.0 (g/kg) |
| Cooked pigs' oil | 12.95 | AP | 3.5 (g/kg) |
| Additives | 0.75 | Lys | 10.0 (g/kg) |
| Lys | 0.12 | Met | 3.8 (g/kg) |
| Met | 0.12 | ||
| CaHPO4 | 1.11 | ||
| Limestone meal | 1.52 | ||
| Salt | 0.13 | ||
The additives contains 0.50% of microelements, per kg dietary contains Fe 80 mg, Zn 40 mg, Cu 8 mg, Mn 60 mg, I 0.35 mg, Se 0.15 mg, 0.20% of choline, Va 1,500 IU, VD3 200 IU, VE 10 IU, VK3 0.05 mg, VB1 1.80 mg, VB2 3.60 mg, VB12 0.01 mg, VB7 0.15 mg, VB9 0.55 mg, VB5 35 mg, VB3 10 mg, VB6 3.50 mg.
The mortality and weight gain in the fifth wk.
| Groups | Numbers | Mortality % | Mean mass gain (kg) |
|---|---|---|---|
| Control group | 12 | 0 | 2.190 ± 0.86 |
| Model group | 12 | 17 | 1.904 ± 0.66∗∗ |
| Drug group | 12 | 0 | 2.015 ± 0.72 |
∗∗Means P < 0.01 vs. control group.
Figure 1Network analysis of targets. “drug–compound–target–disease” network. Blue indicates drug–disease intersection targets. Red indicates NAFLD disease, and other colors indicate active compounds. Abbreviation: NAFLD, nonalcoholic fatty liver disease.
Figure 2Bioinformatic analyses of drug-disease intersection proteins. (A) Gene ontology annotations; (B) KEGG annotation. Abbreviation: KEGG, Kyoto Encyclopedia of Genes and Genomes.
Figure 3Intestinal infection was mainly distributed in the enteritis and NAFLD. (A) the Salmonella infection pathway; (B) Toll-like receptor signaling pathway; (C) apoptosis pathway. Abbreviation: NAFLD, nonalcoholic fatty liver disease.
Contents of TG (mmol/L) and LPS(EU/mL) in serum.
| Groups | Control group | Model group | Drug group |
|---|---|---|---|
| TG | 0.52 ± 0.15 | 0.99 ± 0.20∗∗ | 0.60 ± 0.33 |
| LPS | 0.06 ± 0.00 | 0.09 ± 0.01∗∗ | 0.07 ± 0.01 |
∗∗means P < 0.01 vs. control group.
The cell cycles and apoptosis of the liver cell (%).
| Item | Control group | Model group | Drug group |
|---|---|---|---|
| G0/1 | 70.67 ± 2.76 | 74.92 ± 2.28∗ | 72.83 ± 4.89 |
| S | 7.51 ± 3.29 | 6.32 ± 2.84 | 11.46 ± 2.08∗∗ |
| G2M | 7.84 ± 0.88 | 7.34 ± 1.64 | 9.53 ± 2.16∗ |
| apoptosis | 11.82 ± 2.68 | 11.42 ± 2.69 | 8.34 ± 3.25∗∗ |
| PI | 17.41 ± 3.65 | 15.42 ± 2.97 | 22.90 ± 3.42∗ |
| SPF | 8.52 ± 3.42 | 7.13 ± 2.66 | 12.50 ± 2.78∗∗ |
Abbreviations: PI, proliferation index; SPF, S-phase fraction.
∗P < 0.05
∗∗P < 0.01 vs. control group.